Phospholipase D1 is an effector of Rheb in the mTOR pathway

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 24, 2008, Pages 8286-8291

  Sun, Y ^a   Fang, Y ^a   Yoon, M S ^a   Zhang, C ^a   Roccio, M ^b   Zwartkruis, F J ^b   Armstrong, M ^c   Brown, H A ^c   Chen, J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Phosphatidic acid; Rapamycin; Tuberous sclerosis complex

Indexed keywords

ADENYLATE KINASE; AMINO ACID; ANTINEOPLASTIC AGENT; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; RAPAMYCIN; RHEB PROTEIN; TUBERIN; TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CELL LINE; HUMANS; MONOMERIC GTP-BINDING PROTEINS; NEUROPEPTIDES; PHOSPHOLIPASE D; PROTEIN KINASES; RNA INTERFERENCE; RNA, SMALL NUCLEAR; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA;

EID: 46149098447     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0712268105     Document Type: Article

References (40)

1. Fingar DC, Blenis J (2004) Target of rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151-3171.
2. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18:1926-1945.
3. Sarbassov DD, Ali SM, Sabatini DM (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17:596-603.
4. Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J (2001) Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294:1942-1945.
5. Foster DA (2007) Regulation of mTOR by phosphatidic acid? Cancer Res 67:1-4.
6. Fang Y, et al. (2003) PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1. Curr Biol 13:2037-2044.
7. Chen Y, Zheng Y, Foster DA (2003) Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene 22:3937-3942.
8. Hornberger TA, et al. (2006) The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. Proc Natl Acad Sci USA 103:4741-4746.
9. Exton JH (1999) Regulation of phospholipase D. Biochim Biophys Acta 1439:121-133.
10. Frohman MA, Sung TC, Morris AJ (1999) Mammalian phospholipase D structure and regulation. Biochim Biophys Acta 1439:175-186.
11. Li Y, Corradetti MN, Inoki K, Guan KL (2004) TSC2: Filling the GAP in the mTOR signaling pathway. Trends Biochem Sci 29:32-38.
12. Manning BD, Cantley LC (2003) Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 28:573-576.
13. Nobukuni T, et al. (2005) Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci USA 102:14238-14243.
14. Smith EM, Finn SG, Tee AR, Browne GJ, Proud CG (2005) The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. J Biol Chem 280:18717-18727.
15. Roccio M, Bos JL, Zwartkruis FJ (2006) Regulation of the small GTPase Rheb by amino acids. Oncogene 25:657-664.
16. Kim DH, et al. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163-175.
17. Byfield MP, Murray JT, Backer JM (2005) hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J Biol Chem 280:33076-33082.
18. Long X, Lin Y, Ortiz-Vega S, Yonezawa K, Avruch J (2005) Rheb binds and regulates the mTOR kinase. Curr Biol 15:702-713.
19. Ha SH, et al. (2006) PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals. Cell Signal 12:2283-2291.
20. Yoon MS, Chen J (2008) PLD regulates myoblast differentiation through the mTOR-IGF2 pathway. J Cell Sci 121:282-289.
21. Inoki K, Li Y, Xu T, Guan KL (2003) Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17:1829-1834.
22. Castro AF, Rebhun JF, Clark GJ, Quilliam LA (2003) Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem 278:32493-32496.
23. Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13:1259-1268.
24. Tabancay AP, Jr, et al. (2003) Identification of dominant negative mutants of Rheb GTPase and their use to implicate the involvement of human Rheb in the activation of p70S6K. J Biol Chem 278:39921-39930.
25. Li Y, Inoki K, Guan KL (2004) Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Mol Cell Biol 24:7965-7975.
26. Garami A, et al. (2003) Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 11:1457-1466.
27. Jin F, et al. (1996) Suppression of tumorigenicity by the WT tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci USA 93:9154-9159.
28. Kotter K, et al. (2000) Activation of astroglial phospholipase D activity by phorbol ester involves ARF and Rho proteins. Biochim Biophys Acta 1485:153-162.
29. Luo JQ, et al. (1998) Functional association between Arf and RalA in active phospholipase D complex. Proc Natl Acad Sci USA 95:3632-3637.
30. Im E, et al. (2002) Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells. Oncogene 21:6356-6365.
31. Zhang Y, et al. (2003) Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 5:578-581.
32. Bai X, et al. (2007) Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38. Science 318:977-980.
33. Tee AR, et al. (2002) Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 99:13571-13576.
34. Rebhun JF, Chen H, Quilliam LA (2000) Identification and characterization of a new family of guanine nucleotide exchange factors for the ras-related GTPase Ral. J Biol Chem 275:13406-13410.
35. Xiao N, Du G, Frohman MA (2005) Peroxiredoxin II functions as a signal terminator for H2O2-activated phospholipase D1. FEBS J 272:3929-3937.
36. Kim JH, Kim JE, Liu HY, Cao W, Chen J (2007) Regulation of IL-6 induced hepatic insulin resistance by mtor through the STAT3-SOCS3 pathway. J Biol Chem 283:708-715.
37. Morris AJ, Frohman MA, Engebrecht J (1997) Measurement of phospholipase D activity. Anal Biochem 252:1-9.
38. Du G, et al. (2000) Dual requirement for rho and protein kinase C in direct activation of phospholipase D1 through G protein-coupled receptor signaling. Mol Biol Cell 11:4359-4368.
39. Brown HA, Gutowski S, Moomaw CR, Slaughter C, Sternweis PC (1993) ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity. Cell 75:1137-1144.
40. Rudge SA, Morris AJ, Engebrecht J (1998) Relocalization of phospholipase D activity mediates membrane formation during meiosis. J Cell Biol 140:81-90.